-DOCSTART- -X- O
BACKGROUND -X- _ O
: -X- _ O
Respiratory -X- _ O
syncytial -X- _ O
virus -X- _ O
( -X- _ O
RSV -X- _ O
) -X- _ O
is -X- _ O
the -X- _ O
most -X- _ O
important -X- _ O
cause -X- _ O
of -X- _ O
viral -X- _ O
pneumonia -X- _ O
in -X- _ O
children -X- _ O
worldwide. -X- _ O
A -X- _ O
maternal -X- _ O
vaccine -X- _ O
may -X- _ O
protect -X- _ O
both -X- _ O
the -X- _ O
mother -X- _ O
and -X- _ O
infant -X- _ O
from -X- _ O
RSV -X- _ O
illness. -X- _ O
The -X- _ O
epidemiology -X- _ O
and -X- _ O
clinical -X- _ O
presentation -X- _ O
of -X- _ O
RSV -X- _ B-Patient
in -X- _ I-Patient
pregnant -X- _ I-Patient
and -X- _ I-Patient
postpartum -X- _ I-Patient
women -X- _ I-Patient
is -X- _ O
not -X- _ O
well-described. -X- _ O
METHODS -X- _ O
: -X- _ O
Data -X- _ O
were -X- _ O
collected -X- _ O
from -X- _ O
a -X- _ O
prospective -X- _ O
, -X- _ O
randomized -X- _ O
trial -X- _ O
of -X- _ O
influenza -X- _ O
immunization -X- _ O
in -X- _ O
pregnant -X- _ O
women -X- _ O
in -X- _ O
rural -X- _ O
southern -X- _ O
Nepal. -X- _ O
Women -X- _ O
were -X- _ O
enrolled -X- _ O
in -X- _ O
their -X- _ O
second -X- _ O
trimester -X- _ O
of -X- _ O
pregnancy -X- _ O
and -X- _ O
followed -X- _ O
until -X- _ O
six -X- _ O
months -X- _ O
postpartum. -X- _ O
Active -X- _ O
weekly -X- _ O
home- -X- _ O
based -X- _ O
surveillance -X- _ O
for -X- _ O
febrile -X- _ O
respiratory -X- _ O
illness -X- _ O
was -X- _ O
performed. -X- _ O
Mid-nasal -X- _ O
swabs -X- _ O
collected -X- _ O
with -X- _ O
episodes -X- _ O
of -X- _ O
respiratory -X- _ O
illness -X- _ O
were -X- _ O
tested -X- _ O
for -X- _ O
RSV -X- _ O
by -X- _ O
real-time -X- _ O
polymerase -X- _ O
chain -X- _ O
reaction. -X- _ O
RESULTS -X- _ O
: -X- _ O
RSV -X- _ B-Outcome
was -X- _ I-Outcome
detected -X- _ I-Outcome
in -X- _ I-Outcome
14 -X- _ I-Outcome
( -X- _ I-Outcome
0.4 -X- _ I-Outcome
% -X- _ I-Outcome
) -X- _ I-Outcome
illness -X- _ I-Outcome
episodes -X- _ I-Outcome
in -X- _ I-Outcome
3693 -X- _ I-Outcome
women -X- _ I-Outcome
over -X- _ I-Outcome
3554 -X- _ I-Outcome
person- -X- _ I-Outcome
years -X- _ I-Outcome
of -X- _ I-Outcome
surveillance -X- _ I-Outcome
from -X- _ I-Outcome
2011â€“2014. -X- _ I-Outcome
RSV -X- _ I-Outcome
incidence -X- _ I-Outcome
was -X- _ I-Outcome
3.9 -X- _ I-Outcome
/ -X- _ I-Outcome
1000 -X- _ I-Outcome
person-years -X- _ I-Outcome
overall -X- _ I-Outcome
, -X- _ I-Outcome
and -X- _ I-Outcome
11.8 -X- _ I-Outcome
/ -X- _ I-Outcome
1000 -X- _ I-Outcome
person-years -X- _ I-Outcome
between -X- _ I-Outcome
September -X- _ I-Outcome
and -X- _ I-Outcome
December. -X- _ I-Outcome
Seven -X- _ I-Outcome
( -X- _ I-Outcome
50 -X- _ I-Outcome
% -X- _ I-Outcome
) -X- _ I-Outcome
women -X- _ I-Outcome
sought -X- _ I-Outcome
care -X- _ I-Outcome
for -X- _ I-Outcome
RSV -X- _ I-Outcome
illness -X- _ I-Outcome
; -X- _ I-Outcome
none -X- _ I-Outcome
died. -X- _ I-Outcome
Of -X- _ I-Outcome
the -X- _ I-Outcome
7 -X- _ I-Outcome
( -X- _ I-Outcome
50 -X- _ I-Outcome
% -X- _ I-Outcome
) -X- _ I-Outcome
illness -X- _ I-Outcome
episodes -X- _ I-Outcome
during -X- _ I-Outcome
pregnancy -X- _ I-Outcome
, -X- _ I-Outcome
all -X- _ I-Outcome
had -X- _ I-Outcome
live -X- _ I-Outcome
births -X- _ I-Outcome
with -X- _ I-Outcome
2 -X- _ I-Outcome
( -X- _ I-Outcome
29 -X- _ I-Outcome
% -X- _ I-Outcome
) -X- _ I-Outcome
preterm -X- _ I-Outcome
births -X- _ I-Outcome
and -X- _ I-Outcome
a -X- _ I-Outcome
median -X- _ I-Outcome
birthweight -X- _ I-Outcome
of -X- _ I-Outcome
3060 -X- _ I-Outcome
grams. -X- _ I-Outcome
This -X- _ I-Outcome
compares -X- _ I-Outcome
to -X- _ I-Outcome
469 -X- _ I-Outcome
( -X- _ I-Outcome
13 -X- _ I-Outcome
% -X- _ I-Outcome
) -X- _ I-Outcome
preterm -X- _ I-Outcome
births -X- _ I-Outcome
and -X- _ I-Outcome
a -X- _ I-Outcome
median -X- _ I-Outcome
birthweight -X- _ I-Outcome
of -X- _ I-Outcome
2790 -X- _ I-Outcome
grams -X- _ I-Outcome
in -X- _ I-Outcome
women -X- _ I-Outcome
without -X- _ I-Outcome
RSV -X- _ I-Outcome
during -X- _ I-Outcome
pregnancy. -X- _ I-Outcome
Of -X- _ I-Outcome
the -X- _ I-Outcome
7 -X- _ I-Outcome
mothers -X- _ I-Outcome
with -X- _ I-Outcome
postpartum -X- _ I-Outcome
RSV -X- _ I-Outcome
infection -X- _ I-Outcome
, -X- _ I-Outcome
RSV -X- _ I-Outcome
was -X- _ I-Outcome
detected -X- _ I-Outcome
in -X- _ I-Outcome
4 -X- _ I-Outcome
( -X- _ I-Outcome
57 -X- _ I-Outcome
% -X- _ I-Outcome
) -X- _ I-Outcome
of -X- _ I-Outcome
their -X- _ I-Outcome
infants. -X- _ I-Outcome
CONCLUSIONS -X- _ O
: -X- _ O
RSV -X- _ B-Outcome
was -X- _ I-Outcome
an -X- _ I-Outcome
uncommon -X- _ I-Outcome
cause -X- _ I-Outcome
of -X- _ O
febrile -X- _ B-Patient
respiratory -X- _ I-Patient
illness -X- _ I-Patient
in -X- _ I-Patient
mothers -X- _ I-Patient
during -X- _ I-Patient
pregnancy -X- _ I-Patient
in -X- _ O
Nepal. -X- _ O
These -X- _ O
data -X- _ O
will -X- _ O
inform -X- _ O
prevention -X- _ O
and -X- _ O
therapeutic -X- _ O
strategies -X- _ O
against -X- _ O
RSV -X- _ O
in -X- _ O
resource-limited -X- _ O
settings -X- _ O
. -X- _ O

